deferoxamine has been researched along with chitosan in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barry, FP; Duffy, GP; Hastings, CL; Kelly, HM; Murphy, MJ; O'Brien, FJ | 1 |
| Brundu, A; Cerri, G; Cossu, M; Dalpiaz, A; Ferraro, L; Gavini, E; Giunchedi, P; Marchetti, N; Rassu, G; Regan, RF; Soddu, E | 1 |
| Gavini, E; Giunchedi, P; Porcu, EP; Rassu, G; Roldo, M; Salis, A | 1 |
| Chen, H; Cui, W; Deng, L; Guo, L; Jia, P; Jiang, M; Kang, H; Liu, Y; Qi, J; Santos, HA; Yan, Y; Yang, P; Zhang, H; Zuo, G | 1 |
| Boutin, H; Brown, G; Ellis, B; Fairclough, M; Jones, AK; Locatelli, P; McMahon, A; Prenant, C | 1 |
| Deckers, R; Duffy, GP; Hastings, CL; Hennink, WE; Herron, CC; Kelly, HM; Lopez Noriega, A; McDonnell, CO; O'Brien, FJ; O'Neill, HS; Ruiz-Hernández, E | 1 |
| A, S; Annapoorna, M; R, J; S, V; Shantikumar V, N; Subramania, I | 1 |
| Koodali, RT; Liu, Y; Selvaratnam, B; Sun, H; Yao, Q | 1 |
| Gorgin Karaji, Z; Kazemi, MH; Sajadimajd, S | 1 |
| Chen, D; Hu, MY; Li, GF; Wu, HM; Yu, ML | 1 |
10 other study(ies) available for deferoxamine and chitosan
| Article | Year |
|---|---|
Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia.
Topics: Angiogenesis Inducing Agents; Cell Movement; Cell Proliferation; Cells, Cultured; Chitosan; Deferoxamine; Delayed-Action Preparations; Extremities; Glycerophosphates; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Mesenchymal Stem Cells; Neovascularization, Physiologic; Rheology; Temperature | 2012 |
Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.
Topics: Animals; beta-Cyclodextrins; Biological Transport; Brain; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Deferoxamine; Drug Carriers; Humans; Male; Membranes, Artificial; Microspheres; Nasal Mucosa; Permeability; Rats, Wistar; Siderophores; Swine | 2015 |
Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases.
Topics: Alginates; Chemistry, Pharmaceutical; Chitosan; Deferoxamine; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Hydrogels; Iron; Lactic Acid; Metabolic Diseases; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Viscosity | 2016 |
Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound.
Topics: Animals; Biocompatible Materials; Chitosan; Deferoxamine; Dermis; Diabetes Mellitus, Experimental; Drug Liberation; Fibroblasts; Fluorescence; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Male; Nanofibers; Neovascularization, Physiologic; Polyvinyl Alcohol; Rats, Sprague-Dawley; Signal Transduction; Tissue Scaffolds; Up-Regulation; Vascular Endothelial Growth Factor A; Wound Healing | 2016 |
A new technique for the radiolabelling of mixed leukocytes with zirconium-89 for inflammation imaging with positron emission tomography.
Topics: Chitosan; Copper Radioisotopes; Deferoxamine; Humans; Inflammation; Isotope Labeling; Leukocytes; Nanoparticles; Positron-Emission Tomography; Radioisotopes; Zirconium | 2016 |
A stimuli responsive liposome loaded hydrogel provides flexible on-demand release of therapeutic agents.
Topics: Biocompatible Materials; Cell Movement; Chitosan; Deferoxamine; Drug Liberation; Glycerophosphates; Hepatocyte Growth Factor; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hyperthermia, Induced; Liposomes; Mesenchymal Stem Cells; Vascular Endothelial Growth Factor A | 2017 |
Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
Topics: Animals; Cells, Cultured; Chitosan; Deferoxamine; Delayed-Action Preparations; Drug Liberation; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections; Lactic Acid; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Physiologic; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2018 |
Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Cell Differentiation; Chitosan; Deferoxamine; Drug Delivery Systems; Drug Liberation; Gelatin; Humans; Mesenchymal Stem Cells; Mice; Nanofibers; Nanoparticles; Osteogenesis; Porosity; Silicates; Time Factors; Tissue Engineering | 2018 |
In vitro investigation of wound healing performance of PVA/chitosan/silk electrospun mat loaded with deferoxamine and ciprofloxacin.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Deferoxamine; Humans; Nanofibers; Polyvinyl Alcohol; Silk; Wound Healing | 2023 |
[Effect of sodium alginate-g-deferoxamine/chitosan microspheres on osteogenic differentiation of rat bone mesenchymal stem cells].
Topics: Alginates; Animals; Cell Differentiation; Cells, Cultured; Chitosan; Deferoxamine; Mesenchymal Stem Cells; Microspheres; Osteogenesis; Rats | 2023 |